255 related articles for article (PubMed ID: 17605140)
1. Betulin binds to melanocortin receptors and antagonizes alpha-melanocyte stimulating hormone induced cAMP generation in mouse melanoma cells.
Muceniece R; Saleniece K; Riekstina U; Krigere L; Tirzitis G; Ancans J
Cell Biochem Funct; 2007; 25(5):591-6. PubMed ID: 17605140
[TBL] [Abstract][Full Text] [Related]
2. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
[TBL] [Abstract][Full Text] [Related]
3. New melanocortin 1 receptor binding motif based on the C-terminal sequence of alpha-melanocyte-stimulating hormone.
Schiöth HB; Muceniece R; Mutule I; Wikberg JE
Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):287-93. PubMed ID: 17040213
[TBL] [Abstract][Full Text] [Related]
4. [Detection of binding activity and biologic effect of a novel alpha-melanocyte-stimulating hormone analogue].
Ying Y; Lan XP; Tian YP
Yao Xue Xue Bao; 2007 Mar; 42(3):269-73. PubMed ID: 17520825
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel melanocortin4 receptor selective MSH analogues.
Schiöth HB; Mutulis F; Muceniece R; Prusis P; Wikberg JE
Br J Pharmacol; 1998 May; 124(1):75-82. PubMed ID: 9630346
[TBL] [Abstract][Full Text] [Related]
6. Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014: comparison with SHU9119.
Schiöth HB; Muceniece R; Mutulis F; Bouifrouri AA; Mutule I; Wikberg JE
Neuropeptides; 1999 Jun; 33(3):191-6. PubMed ID: 10657491
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of melanocortin peptides on neural melanocortin receptors.
Adan RA; Cone RD; Burbach JP; Gispen WH
Mol Pharmacol; 1994 Dec; 46(6):1182-90. PubMed ID: 7808440
[TBL] [Abstract][Full Text] [Related]
8. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
9. The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alpha-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components.
Grässel S; Opolka A; Anders S; Straub RH; Grifka J; Luger TA; Böhm M
Arthritis Rheum; 2009 Oct; 60(10):3017-27. PubMed ID: 19790046
[TBL] [Abstract][Full Text] [Related]
10. Further evidence for ancient role of ACTH peptides at melanocortin (MC) receptors; pharmacology of dogfish and lamprey peptides at dogfish MC receptors.
Haitina T; Takahashi A; Holmén L; Enberg J; Schiöth HB
Peptides; 2007 Apr; 28(4):798-805. PubMed ID: 17306418
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the binding of MSH-B, HB-228, GHRP-6 and 153N-6 to the human melanocortin receptor subtypes.
Schiöth HB; Muceniece R; Wikberg JE
Neuropeptides; 1997 Dec; 31(6):565-71. PubMed ID: 9574823
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of a novel human melanocortin receptor.
Chhajlani V; Muceniece R; Wikberg JE
Biochem Biophys Res Commun; 1993 Sep; 195(2):866-73. PubMed ID: 8396929
[TBL] [Abstract][Full Text] [Related]
13. Agouti protein inhibits growth of B16 melanoma cells in vitro by acting through melanocortin receptors.
Siegrist W; Willard DH; Wilkison WO; Eberle AN
Biochem Biophys Res Commun; 1996 Jan; 218(1):171-5. PubMed ID: 8573126
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of two melanocortin (MC) receptors in lamprey showing orthology to the MC1 and MC4 receptor subtypes.
Haitina T; Klovins J; Takahashi A; Löwgren M; Ringholm A; Enberg J; Kawauchi H; Larson ET; Fredriksson R; Schiöth HB
BMC Evol Biol; 2007 Jun; 7():101. PubMed ID: 17603878
[TBL] [Abstract][Full Text] [Related]
15. Phenylguanidines as selective nonpeptide melanocortin-5 receptor antagonists.
Chen C; Yu J; Fleck BA; Hoare SR; Saunders J; Foster AC
J Med Chem; 2004 Jul; 47(16):4083-8. PubMed ID: 15267247
[TBL] [Abstract][Full Text] [Related]
16. Interaction of melanin-concentrating hormone (MCH), neuropeptide E-I (NEI), neuropeptide G-E (NGE), and alpha-MSH with melanocortin and MCH receptors on mouse B16 melanoma cells.
Hintermann E; Tanner H; Talke-Messerer C; Schlumberger S; Zumsteg U; Eberle AN
J Recept Signal Transduct Res; 2001 Feb; 21(1):93-116. PubMed ID: 11693176
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the differential expression of the functional alpha-melanocyte-stimulating hormone receptor MC-1 on human monocytes.
Bhardwaj R; Becher E; Mahnke K; Hartmeyer M; Schwarz T; Scholzen T; Luger TA
J Immunol; 1997 Apr; 158(7):3378-84. PubMed ID: 9120297
[TBL] [Abstract][Full Text] [Related]
18. ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors.
Fong TM; Mao C; MacNeil T; Kalyani R; Smith T; Weinberg D; Tota MR; Van der Ploeg LH
Biochem Biophys Res Commun; 1997 Aug; 237(3):629-31. PubMed ID: 9299416
[TBL] [Abstract][Full Text] [Related]
19. Subtype-specific pharmacological properties of the melanocortin receptors in chicken.
Ling MK; Schiöth HB
Ann N Y Acad Sci; 2005 Apr; 1040():378-80. PubMed ID: 15891067
[TBL] [Abstract][Full Text] [Related]
20. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
Mountjoy KG; Willard DH; Wilkison WO
Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
